Previous close | 0.3200 |
Open | 0.5100 |
Bid | 0.4700 |
Ask | 0.5900 |
Strike | 12.00 |
Expiry date | 2025-12-19 |
Day's range | 0.5100 - 0.5100 |
Contract range | N/A |
Volume | |
Open interest | 1.1k |
Peloton isn't profitable as a subscription business, but it looks different as a media company.
Amgen is the latest biotech to benefit from obesity drug optimism, Sony and Apollo offer Paramount Global $26 billion cash in takeover move, and other news to start your day.
Amidst leadership transitions and market adjustments, Peloton reports a significant quarter with strategic restructuring and a focus on sustainable growth.